Skip to main content
Addgene

Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1.

Hu N, Antoury L, Baran TM, Mitra S, Bennett CF, Rigo F, Foster TH, Wheeler TM
Nat Commun. 2018 Dec 7;9(1):5227. doi: 10.1038/s41467-018-07517-y. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
179083TR therapy reporterFluorescent reporter for alternative splicing

Antibodies from Article